Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study

European Journal of Health Economics

Volumn 16, Issue 6, 2015, Pages 671-681

  Seidl, Hildegard ^a   Hunger, Matthias ^a   Leidl, Reiner ^a   Meisinger, Christa ^a,b   Wende, Rupert ^b   Kuch, Bernhard ^c   Holle, Rolf ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c Donau Ries Kliniken   (Germany)

Author keywords

Case management; Cost effectiveness analysis; Elderly; Myocardial infarction; Quality adjusted life years

Indexed keywords

AGED; ARTICLE; CASE MANAGEMENT; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH STATUS; HEART INFARCTION; HUMAN; NURSING INTERVENTION; NURSING MANAGEMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SURVIVOR; TELEPHONE INTERVIEW; ACUTE DISEASE; AGE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MYOCARDIAL INFARCTION; NURSE; ORGANIZATION AND MANAGEMENT; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VERY ELDERLY;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE MANAGEMENT; COST-BENEFIT ANALYSIS; FEMALE; HEALTH STATUS; HUMANS; MALE; MYOCARDIAL INFARCTION; NURSES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SEX FACTORS;

EID: 84930864420     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0623-3     Document Type: Article

References (50)

1. World Health Organization: The top 10 causes of death http://who.int/mediacentre/factsheets/fs310/en/. Accessed 15 Oct 2013
2. Mannsverk, J., Wilsgaard, T., Njolstad, I., Hopstock, L.A., Lochen, M.L., Mathiesen, E.B., Thelle, D.S., Rasmussen, K., Bonaa, K.H.: Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev cardiol 19(5), 927–934 (2012)
3. Robert Koch Institute, Telephone Health Survey (GEDA): Coronary heart diseases, diagnosed by a physician. http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=i&p_aid=6990894&nummer=762&p_sprache=E&p_indsp=-&p_aid=97416972. Accessed May 2014
4. Fleg, J.L., Forman, D.E., Berra, K., Bittner, V., Blumenthal, J.A., Chen, M.A., Cheng, S., Kitzman, D.W., Maurer, M.S., Rich, M.W., Shen, W.K., Williams, M.A., Zieman, S.J.: Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circ 128(22), 2422–2446 (2013). doi:10.1161/01.cir.0000436752.99896.22
5. Kotseva, K., Wood, D., De Backer, G., De Bacquer, D.: Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol 20(5), 817–826 (2013). doi:10.1177/2047487312449591
6. Clark, A.M., Haykowsky, M., Kryworuchko, J., MacClure, T., Scott, J., DesMeules, M., Luo, W., Liang, Y., McAlister, F.A.: A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur J Cardiovasc Prev Rehabil 17(3), 261–270 (2010)
7. McAlister, F.A., Lawson, F.M., Teo, K.K., Armstrong, P.W.: A systematic review of randomized trials of disease management programs in heart failure. Am. J. Med. 110(5), 378–384 (2001)
8. Schadewaldt, V., Schultz, T.: Nurse-led clinics as an effective service for cardiac patients: results from a systematic review. Int J Evid-Based Healthc 9(3), 199–214 (2011). doi:10.1111/j.1744-1609.2011.00217.x
9. Stolic, S., Mitchell, M., Wollin, J.: Nurse-led telephone interventions for people with cardiac disease: a review of the research literature. Eur J Cardiovasc Nurs 9(4), 203–217 (2010). doi:10.1016/j.ejcnurse.2010.02.003
10. Raftery, J.P., Yao, G.L., Murchie, P., Campbell, N.C., Ritchie, L.D.: Cost effectiveness of nurse-led secondary prevention clinics for coronary heart disease in primary care: follow-up of a randomised controlled trial. BMJ 330(7493), 707 (2005). doi:10.1136/bmj.38342.665417.8F
11. Turkstra, E., Hawkes, A.L., Oldenburg, B., Scuffham, P.A.: Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart). BMC Cardiovasc Disord 13(1), 33 (2013). doi:10.1186/1471-2261-13-33 18
12. Turner, D.A., Paul, S., Stone, M.A., Juarez-Garcia, A., Squire, I., Khunti, K.: Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care. Heart 94(12), 1601–1606 (2008). doi:10.1136/hrt.2007.125708
13. Hebert, P.L., Sisk, J.E., Wang, J.J., Tuzzio, L., Casabianca, J.M., Chassin, M.R., Horowitz, C., McLaughlin, M.A.: Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community. Ann. Intern. Med. 149(8), 540–548 (2008)
14. Postmus, D., Pari, A.A., Jaarsma, T., Luttik, M.L., van Veldhuisen, D.J., Hillege, H.L., Buskens, E.: A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure. Am. Heart J. 162(6), 1096–1104 (2011). doi:10.1016/j.ahj.2011.09.019
15. Smith, B., Hughes-Cromwick, P.F., Forkner, E., Galbreath, A.D.: Cost-effectiveness of telephonic disease management in heart failure. Am J Manag Care 14(2), 106–115 (2008). Pii: 7020
16. Kirchberger, I., Meisinger, C., Seidl, H., Wende, R., Kuch, B., Holle, R.: Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial. BMC geriatr 10, 29 (2010)
17. Meisinger, C., Stollenwerk, B., Kirchberger, I., Seidl, H., Wende, R., Kuch, B., Holle, R.: Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study. BMC Geriatr 13(1), 115 (2013). doi:10.1186/1471-2318-13-115
18. Hunger, M., Kirchberger, I., Holle, R., Seidl, H., Kuch, B., Wende, R., Meisinger, C.: Does nurse-based case management for aged myocardial infarction patients improve risk factors, physical functioning and mental health? The KORINNA trial. Eur J Prev Cardiol (2014). doi:10.1177/2047487314524682
19. Stark, R., Kirchberger, I., Hunger, M., Heier, M., Leidl, R., von Scheidt, W., Meisinger, C., Holle, R.: Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clini Res Cardiol:Off J Ger Card Soc. 103(3), 237–245 (2014). doi:10.1007/s00392-013-0643-5
20. Nowels, D., McGloin, J., Westfall, J.M., Holcomb, S.: Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual. Life Res. 14(1), 95–105 (2005)
21. Schweikert, B., Hahmann, H., Leidl, R.: Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 92(1), 62–67 (2006). doi:10.1136/hrt.2004.052787
22. Russell, K., Freeman, A., Blue, L., Stewart, S.: a blueprint for identifying and managing patients within a heart failure Service. 2nd eds. In: Improving Outcomes in Chronic Heart Failure: Specialist Nurse Intervention from Research to Practice. BMJ Publishing Group, London (2004)
23. Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6(2), 124–130 (2005)
24. Drummond, M.F., Sculpher, M.J., Torrance, G.W., O’Brien, B.J., Stoddart, G.L.: Methods for the economic evaluation of health care programmes. 3rd ed. Oxford University Press, Oxford (2005) 19
25. Goossens, M.E.: Rutten-van Molken, M.P., Vlaeyen, J.W., van der Linden, S.M.: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J. Clin. Epidemiol. 53(7), 688–695 (2000). Pii: S0895435699001778
26. Seidl, H., Meisinger, C., Wende, R., Holle, R.: Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials. BMC Health Serv Res 12, 318 (2012). doi:10.1186/1472-6963-12-318
27. Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., Schweikert, B.: Empirical standard costs for health economic evaluation in Germany—a proposal by the working group methods in health economic evaluation. Gesundheitswesen 67(10), 736–746 (2005). doi:10.1055/s-2005-858698
28. GKV-Heilmittel-Informationssystem.http://www.gkv-his.de/Aktuelle_Quartalsberichte.gkvnet. (Accessed 12 Jan 2013)
29. Standardtarif http://www.debeka.de/service/bedingungen/Krankenversicherung/Allgemeine_Bedingungen/CKV50.pdf. (Accessed 13 Dec 2012)
30. Rehabilitation. http://www.deutsche-rentenversicherung-bund.de/cae/servlet/contentblob/89948/publicationFile/19214/statistikband_reha_2010_pdf.pdf;jsessionid=564C005D3595BEEC1AB4D126E3B6AC84.cae03. (Accessed 26 Jan 2013)
31. Vertrag gemäß § 89 SGB XI (2010) http://www.aok-gesundheitspartner.de/imperia/md/gpp/by/pflege/ambulant/by_pflege_amb_pv_vergut_vertrag_anlage3_leistungskomplexe_wohlfahrt.pdf. (Accessed 15 April 2013)
32. Mühlberger, N., Behrend, C., Stark, R., Holle, R.: Database-supported identification and entry of drug data in health studies—experience with the IDOM software [Datenbankgestützte Online-Erfassung von Arzneimitteln im Rahmen gesundheitswissenschaftlicher Studien Erfahrungen mit der IDOM-Software] in German. Inform Biom Epidemiol Med Biol 34(4), 601–611 (2003)
33. Wissenschaftliches Institut der AOK. http://www.wido.de/arzneimittel.html. Accessed 15 January 2013
34. Sozialgesetzbuch (SGB), Elftes Buch (XI), Soziale Pflegeversicherung. http://www.sozialgesetzbuch-sgb.de/sgbxi/1.html. Accessed 15 Apr 2011
35. Manca, A., Hawkins, N., Sculpher, M.J.: Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 14(5), 487–496 (2005). doi:10.1002/hec.944
36. Kahan, B.C., Morris, T.P.: Improper analysis of trials randomised using stratified blocks or minimisation. Stat. Med. 31(4), 328–340 (2012). doi:10.1002/sim.4431
37. Molenberghs, G., Kenward, M.G.: Missing data in clinical studies. John Wiley & Sons Ltd, UK (2007)
38. Dodd, S., Bassi, A., Bodger, K., Williamson, P.: A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract 12(1), 76–86 (2006). doi:10.1111/j.1365-2753.2006.00610.x
39. Glick, H., Doshi, J.A., Sonnad, S.S., Polsky, D.: Economic evaluation in clinical trials. In: Gray, A., Briggs, A. (eds.) Handbooks in health economic evaluation series. Oxford University Press, New York (2007)
40. Graubard, B.I., Korn, E.L.: Predictive margins with survey data. Biometrics 55(2), 652–659 (1999)
41. Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J., Loder, E.: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Val Health 16(2), 231–250 (2013). doi:10.1016/j.jval.2013.02.002
42. Briggs, A.H., Lozano-Ortega, G., Spencer, S., Bale, G., Spencer, M.D., Burge, P.S.: Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. Val Health 9(4), 227–235 (2006). doi:10.1111/j.1524-4733.2006.00106.x
43. Horton, N.J., SR, L.: Multiple imputation in practice: comparison of software packages for regression models with missing variables. Am Statistician 55, 244–254 (2001)
44. Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., Reed, S.: Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Val Health 8(5), 521–533 (2005). doi:10.1111/j.1524-4733.2005.00045.x
45. Sahlen, K.G., Lofgren, C., Brodin, H., Dahlgren, L., Lindholm, L.: Measuring the value of older peopleʼs production: a diary study. BMC Health Serv Res 12, 4 (2012). doi:10.1186/1472-6963-12-4
46. Leidl, R., Reitmeir, P.: A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoecon 29(6), 521–534 (2011). doi:10.2165/11538380-000000000-00000
47. Broome, J.: QALYs. J public econ 50, 149–167 (1993)
48. Dolan, P., Kahneman, D.: Interpretations of utility and their implications for the valuation of health. Econ. J. 118(525), 215–234 (2008)
49. Parkin, D., Devlin, N.: Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ. 15(7), 653–664 (2006). doi:10.1002/hec.1086
50. Hawkes, A.L., Atherton, J., Taylor, C.B., Scuffham, P., Eadie, K., Miller, N.H., Oldenburg, B.: Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients. BMC Cardiovasc Disord 9, 16 (2009). doi:10.1186/1471-2261-9-16